Clarivate PLC (CLVT) Q2 Earnings Match Estimates — Positive

CLVT   Zacks Investment Research — July 30, 2025

Clarivate PLC (CLVT) came out with quarterly earnings of $0.18 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.2 per share a year ago.

image for news Clarivate PLC (CLVT) Q2 Earnings Match Estimates

Entegris (ENTG) Q2 Earnings and Revenues Surpass Estimates — Positive

ENTG   Zacks Investment Research — July 30, 2025

Entegris (ENTG) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.71 per share a year ago.

image for news Entegris (ENTG) Q2 Earnings and Revenues Surpass Estimates

Generac Holdings (GNRC) Q2 Earnings and Revenues Top Estimates — Positive

GNRC   Zacks Investment Research — July 30, 2025

Generac Holdings (GNRC) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.35 per share a year ago.

image for news Generac Holdings (GNRC) Q2 Earnings and Revenues Top Estimates

Bunge Global (BG) Tops Q2 Earnings and Revenue Estimates — Positive

BG   Zacks Investment Research — July 30, 2025

Bunge Global (BG) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.73 per share a year ago.

image for news Bunge Global (BG) Tops Q2 Earnings and Revenue Estimates

LXP Industrial (LXP) Meets Q2 FFO Estimates — Positive

LXP   Zacks Investment Research — July 30, 2025

LXP Industrial (LXP) came out with quarterly funds from operations (FFO) of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.16 per share a year ago.

image for news LXP Industrial (LXP) Meets Q2 FFO Estimates

SANTA CLARA, Calif. , July 30, 2025 /PRNewswire/ -- Palo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, announced today that it will release the financial results for its fiscal fourth quarter and fiscal year 2025, ending July 31, 2025, after U.S. markets close on Monday, August 18, 2025.

image for news Palo Alto Networks to Announce Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results on Monday, August 18, 2025

Amazon's cloud-services business will be a key focus when the e-commerce giant reports earnings, with AWS revenue expected to grow 17%.

image for news Amazon's earnings are due. It needs to prove it isn't a ‘one-hit wonder'

PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its partnership with actor and health advocate James Van Der Beek to increase awareness about colorectal cancer (CRC) screening and the Shield™ blood test. Approved by the U.S. Food and Drug Administration (FDA) last year, Shield offers a convenient and more pleasant new option for CRC screening for eligible individuals 45+. Known for iconic roles in Varsity Blues, Rules.

image for news Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

Helion Energy, a startup backed by OpenAI's Sam Altman and SoftBank's venture capital arm, has started construction on a site for a planned nuclear fusion power plant that will supply power to Microsoft data centers by 2028, the company said on Wednesday.

image for news Helion Energy starts construction on nuclear fusion plant to power Microsoft data centers

SSR Mining: Sitting On A Gold Mine — Positive

SSRM   Seeking Alpha — July 30, 2025

SSRM seems undervalued, with strong financials and trading at a significant discount despite the recent jump in price. The Çöpler mine restart is a key catalyst and I believe its recovery is not priced in, but even without it, the stock currently comes at a high discount. SSR Mining's balance sheet is robust, with low debt, ample liquidity, and growth opportunities through acquisitions and project pipeline.

image for news SSR Mining: Sitting On A Gold Mine

Fiverr International (FVRR) Misses Q2 Earnings Estimates — Negative

FVRR   Zacks Investment Research — July 30, 2025

Fiverr International (FVRR) came out with quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.58 per share a year ago.

image for news Fiverr International (FVRR) Misses Q2 Earnings Estimates

GSK (GSK) Q2 Earnings and Revenues Beat Estimates — Positive

GSK   Zacks Investment Research — July 30, 2025

GSK (GSK) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.09 per share a year ago.

image for news GSK (GSK) Q2 Earnings and Revenues Beat Estimates

SiteOne Landscape (SITE) Q2 Earnings and Revenues Miss Estimates — Negative

SITE   Zacks Investment Research — July 30, 2025

SiteOne Landscape (SITE) came out with quarterly earnings of $2.86 per share, missing the Zacks Consensus Estimate of $2.89 per share. This compares to earnings of $2.63 per share a year ago.

image for news SiteOne Landscape (SITE) Q2 Earnings and Revenues Miss Estimates

Check Point Software (CHKP) Q2 Earnings and Revenues Surpass Estimates — Positive

CHKP   Zacks Investment Research — July 30, 2025

Check Point Software (CHKP) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.17 per share a year ago.

image for news Check Point Software (CHKP) Q2 Earnings and Revenues Surpass Estimates

Vertiv Holdings Co. (VRT) Q2 Earnings and Revenues Surpass Estimates — Positive

VRT   Zacks Investment Research — July 30, 2025

Vertiv Holdings Co. (VRT) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.67 per share a year ago.

image for news Vertiv Holdings Co. (VRT) Q2 Earnings and Revenues Surpass Estimates

UBS (UBS) Beats Q2 Earnings and Revenue Estimates — Positive

UBS   Zacks Investment Research — July 30, 2025

UBS (UBS) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to earnings of $0.34 per share a year ago.

image for news UBS (UBS) Beats Q2 Earnings and Revenue Estimates

CoStar Sues Zillow For Rampant Copyright Infringement — Neutral

CSGP   Business Wire — July 30, 2025

NEW YORK--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a global leader in commercial real estate information, analytics, online marketplaces and 3D digital twin technology, filed a lawsuit in New York federal court today alleging rampant copyright infringement by Zillow. The infringement could hardly be more brazen. The complaint shows that Zillow is unlawfully exploiting tens of thousands of CoStar Group's watermarked photographs on its sites and on Redfin and Realtor.com, making this o.

image for news CoStar Sues Zillow For Rampant Copyright Infringement

United Airlines, JetBlue partnership gets Trump admin clearance to fly — Positive

JBLU  UAL   Fox Business — July 30, 2025

DOT approves United Airlines and JetBlue partnership after Spirit Airlines opposed the deal, with seven daily round-trip flights planned for JFK airport.

image for news United Airlines, JetBlue partnership gets Trump admin clearance to fly

Investor Sentiment Shifting From Nvidia To AMD? — Positive

AMD  NVDA   Seeking Alpha — July 30, 2025

From a candlestick perspective, AMD's recent price action shows clear signs of steady accumulation. Buyers are in control. The recent breakout in the stock suggests that momentum is building, but it remains fundamentally discounted. Taking a look at what could be fueling this sentiment shift beneath the surface - factors like ROCm traction, steady GPU traction with products like the MI300 and MI325X, hyperscaler relationships, and AMD's multi-year roadmap.

image for news Investor Sentiment Shifting From Nvidia To AMD?

NEEDHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel's President and Chief Executive Officer, will present at the Canaccord Genuity 45th Annual Growth Conference, being held on August 12-14, 2025 in Boston, MA.

image for news Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference